These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 38095081)

  • 1. Dual-target inhibitors based on COX-2: a review from medicinal chemistry perspectives.
    Zhang F; Zhu G; Li Y; Qi Y; Wang Z; Li W
    Future Med Chem; 2023 Dec; 15(23):2209-2233. PubMed ID: 38095081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alkaloids as Cyclooxygenase Inhibitors in Anticancer Drug Discovery.
    Hashmi MA; Khan A; Farooq U; Khan S
    Curr Protein Pept Sci; 2018; 19(3):292-301. PubMed ID: 28059042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computer aided drug design approaches to develop cyclooxygenase based novel anti-inflammatory and anti-cancer drugs.
    Reddy RN; Mutyala R; Aparoy P; Reddanna P; Reddy MR
    Curr Pharm Des; 2007; 13(34):3505-17. PubMed ID: 18220787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influencing COX-2 Activity by COX Related Pathways in Inflammation and Cancer.
    Yu T; Lao X; Zheng H
    Mini Rev Med Chem; 2016; 16(15):1230-1243. PubMed ID: 27145850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of novel hybrids of diaryl-1,2,4-triazoles and caffeic acid as dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase for cancer therapy.
    Cai H; Huang X; Xu S; Shen H; Zhang P; Huang Y; Jiang J; Sun Y; Jiang B; Wu X; Yao H; Xu J
    Eur J Med Chem; 2016 Jan; 108():89-103. PubMed ID: 26638042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New oxadiazoles with selective-COX-2 and EGFR dual inhibitory activity: Design, synthesis, cytotoxicity evaluation and in silico studies.
    El-Sayed NA; Nour MS; Salem MA; Arafa RK
    Eur J Med Chem; 2019 Dec; 183():111693. PubMed ID: 31539778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2, 3-Diaryl-5-ethylsulfanylmethyltetrahydrofurans as a new class of COX-2 inhibitors and cytotoxic agents.
    Singh P; Mittal A; Kaur S; Holzer W; Kumar S
    Org Biomol Chem; 2008 Aug; 6(15):2706-12. PubMed ID: 18633528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural-Derived COX-2 Inhibitors as Anticancer Drugs: A Review of their Structural Diversity and Mechanism of Action.
    Mahboubi-Rabbani M; Abbasi M; Zarghi A
    Anticancer Agents Med Chem; 2023; 23(1):15-36. PubMed ID: 35638275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on COX-2 Selective Inhibitors: Chemical Classification, Side Effects and their Use in Cancers and Neuronal Diseases.
    Rayar AM; Lagarde N; Ferroud C; Zagury JF; Montes M; Sylla-Iyarreta Veitia M
    Curr Top Med Chem; 2017; 17(26):2935-2956. PubMed ID: 28828990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel dual cyclooxygenase and lipoxygenase inhibitors targeting hyaluronan-CD44v6 pathway and inducing cytotoxicity in colon cancer cells.
    Misra S; Ghatak S; Patil N; Dandawate P; Ambike V; Adsule S; Unni D; Venkateswara Swamy K; Padhye S
    Bioorg Med Chem; 2013 May; 21(9):2551-9. PubMed ID: 23517721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual COX-2/15-LOX inhibitors: A new avenue in the prevention of cancer.
    Aliabadi A; Khanniri E; Mahboubi-Rabbani M; Bayanati M
    Eur J Med Chem; 2023 Dec; 261():115866. PubMed ID: 37862815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploiting cyclooxygenase-(in)dependent properties of COX-2 inhibitors for malignant glioma therapy.
    Schönthal AH
    Anticancer Agents Med Chem; 2010 Jul; 10(6):450-61. PubMed ID: 20879982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual Human Carbonic Anhydrase/Cyclooxygenase-2 Inhibitors: A Promising Approach for Cancer Treatment.
    Mahboubi-Rabbani M; Zarghi A
    Anticancer Agents Med Chem; 2021 Oct; 21(16):2163-2180. PubMed ID: 33511940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective COX-2 inhibitors as anticancer agents: a patent review (2014-2018).
    Mahboubi Rabbani SMI; Zarghi A
    Expert Opin Ther Pat; 2019 Jun; 29(6):407-427. PubMed ID: 31132889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-based parallel medicinal chemistry approach to improve metabolic stability of benzopyran COX-2 inhibitors.
    Xing L; Hamper BC; Fletcher TR; Wendling JM; Carter J; Gierse JK; Liao S
    Bioorg Med Chem Lett; 2011 Feb; 21(3):993-6. PubMed ID: 21215625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safer anti-inflammatory therapy through dual COX-2/5-LOX inhibitors: A structure-based approach.
    P JJ; Manju SL; Ethiraj KR; Elias G
    Eur J Pharm Sci; 2018 Aug; 121():356-381. PubMed ID: 29883727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and Biological Evaluation of 1,3,5-Trisubstituted 2-Pyrazolines as Novel Cyclooxygenase-2 Inhibitors with Antiproliferative Activity.
    Vahedpour T; Kaur J; Hemmati S; Hamzeh-Mivehroud M; Alizadeh AA; Wuest F; Dastmalchi S
    Chem Biodivers; 2021 Mar; 18(3):e2000832. PubMed ID: 33620122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and biological evaluation of pyridine acyl sulfonamide derivatives as novel COX-2 inhibitors.
    Lu X; Zhang H; Li X; Chen G; Li QS; Luo Y; Ruan BF; Chen XW; Zhu HL
    Bioorg Med Chem; 2011 Nov; 19(22):6827-32. PubMed ID: 22000948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surface plasmon resonance studies and biochemical evaluation of a potent peptide inhibitor against cyclooxygenase-2 as an anti-inflammatory agent.
    Somvanshi RK; Kumar A; Kant S; Gupta D; Singh SB; Das U; Srinivasan A; Singh TP; Dey S
    Biochem Biophys Res Commun; 2007 Sep; 361(1):37-42. PubMed ID: 17640617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Novel Cyclooxygenase-1 Selective Inhibitors of Thiadiazole-Based Scaffold as Potent Anti-Inflammatory Agents with Safety Gastric and Cytotoxic Profile.
    Haroun M; Fesatidou M; Petrou A; Tratrat C; Zagaliotis P; Gavalas A; Venugopala KN; Kochkar H; Emeka PM; Younis NS; Elmaghraby DA; Almostafa MM; Chohan MS; Vizirianakis IS; Papadimitriou-Tsantarliotou A; Geronikaki A
    Molecules; 2023 Apr; 28(8):. PubMed ID: 37110650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.